Elicio Therapeutics Cash Flow Statement (2020-2026) | ELTX

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-18.24M-15.76M14.63M-14.48M-7.30M-6.84M-6.00M-8.14M-8.45M-10.53M-9.32M-10.13M-10.84M-10.30M-13.71M-10.70M-10.12M-8.27M-9.18M-10.85M
Depreciation and Depletion (Quarter)
0.02M0.02M0.03M0.03M0.15M0.10M0.09M0.11M0.10M0.08M0.08M0.10M0.06M0.10M0.10M0.10M0.04M0.05M
Share-based Compensation (Quarter)
2.72M2.18M2.02M0.03M0.24M0.11M0.20M0.22M0.28M0.34M0.34M0.32M0.35M0.31M0.46M0.52M0.71M0.70M0.77M0.87M
Gains from Investment Securities (Quarter)
-0.20M-0.13M-0.73M-0.04M0.02M-0.01M-0.01M1.28M-3.62M5.62M0.86M1.81M0.23M
Cash from Operations (Quarter)
-10.53M-15.20M-14.36M-15.65M6.14M-5.39M-7.28M-8.14M-9.47M-5.18M-9.89M-12.12M-8.93M-7.27M-8.74M-10.12M-8.95M-11.09M-6.80M-11.64M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.18M0.19M0.19M0.20M0.09M0.19M0.19M0.40M0.18M0.21M0.03M-0.56M0.23M0.23M0.40M0.24M0.24M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)
0.02M0.02M0.03M0.03M0.15M0.10M0.09M0.11M0.10M0.08M0.08M0.10M0.06M0.10M0.10M0.10M0.04M0.05M
Change in Working Capital
Change in Account Payables (Quarter)
2.62M-1.66M-2.94M-1.32M3.08M-0.35M-0.28M1.39M-1.46M0.14M-0.04M-3.26M-0.05M0.93M-0.95M3.00M-0.17M-3.54M0.35M-0.46M
Change in Accured Expenses (Quarter)
2.11M0.84M-2.17M2.02M-1.91M-0.18M-0.23M-0.38M0.12M2.16M0.31M-0.43M2.04M-0.51M3.56M-2.65M-0.66M0.11M1.21M-0.60M
Other Working Capital Changes (Quarter)
-0.51M-0.21M-1.65M1.42M1.74M-2.05M-0.51M0.17M-0.25M-0.24M-1.08M0.74M-0.36M-0.21M0.00M-1.17M0.13M0.14M
Investing Activities
Capital Expenditures (Quarter)
0.24M0.06M-0.34M0.56M0.10M0.02M0.00M0.04M0.04M0.04M0.02M
Sales of Property, Plant and Equipment (Quarter)
0.03M0.00M
Cash from Investing Activities (Quarter)
-0.24M-0.06M-0.04M-0.56M-0.10M-0.02M0.03M-0.04M0.00M-0.04M-0.04M-0.02M
Financing Activities
Other financing activities (Quarter)
1.41M0.23M
Cash from Financing Activities (Quarter)
-2.38M0.70M0.40M-0.01M1.26M8.78M11.18M10.04M21.51M0.06M7.00M11.02M0.32M30.75M0.23M10.33M11.93M9.57M4.86M8.03M
Additional items
Exchange Rate Effect (Quarter)
0.01M-0.02M0.01M-0.09M0.09M0.08M-0.08M0.00M-0.04M0.04M0.03M0.03M0.07M0.04M-0.10M0.01M
Change in Cash (Quarter)
-13.14M-14.58M-13.98M-15.75M6.92M3.39M3.81M1.88M12.06M-5.17M-2.89M-1.09M-8.70M23.52M-8.54M0.24M3.06M-1.48M-2.05M-3.61M
Free Cash Flow (Quarter)
-10.78M-15.26M-14.02M-15.65M5.58M-5.39M-7.37M-8.16M-9.48M-5.23M-9.89M-12.12M-8.97M-7.27M-8.79M-10.12M-8.95M-11.09M-6.81M-11.64M
Net Cash Flow (Quarter)
-13.15M-14.56M-13.99M-15.67M6.84M3.39M3.81M1.88M12.07M-5.17M-2.89M-1.09M-8.65M23.48M-8.56M0.21M2.98M-1.51M-1.95M-3.62M